FR2419725A1 - Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales - Google Patents
Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumoralesInfo
- Publication number
- FR2419725A1 FR2419725A1 FR7807155A FR7807155A FR2419725A1 FR 2419725 A1 FR2419725 A1 FR 2419725A1 FR 7807155 A FR7807155 A FR 7807155A FR 7807155 A FR7807155 A FR 7807155A FR 2419725 A1 FR2419725 A1 FR 2419725A1
- Authority
- FR
- France
- Prior art keywords
- compsns
- alstonine
- serpentine
- sempervirine
- antitumoural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D459/00—Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne l'utilisation comme médicaments, utiles notamment pour le traitement des cancers et tumeurs, d'alcaloïdes appartenant au groupe des beta -carbolines quaternaires, tels que la serpentine, l'alstonine et la sempervirine. L'invention concerne également un procédé de préparation de serpentine et d'alstonine l'état pur.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7807155A FR2419725A1 (fr) | 1978-03-13 | 1978-03-13 | Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales |
FR7830663A FR2439783A1 (fr) | 1978-03-13 | 1978-10-27 | Procede d'extraction de la serpentine et de l'alstonine |
FR7905853A FR2450607A2 (fr) | 1978-03-13 | 1979-03-07 | Composition pharmaceutique contenant comme principe actif la flavopereine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7807155A FR2419725A1 (fr) | 1978-03-13 | 1978-03-13 | Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2419725A1 true FR2419725A1 (fr) | 1979-10-12 |
FR2419725B1 FR2419725B1 (fr) | 1981-10-23 |
Family
ID=9205684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7807155A Granted FR2419725A1 (fr) | 1978-03-13 | 1978-03-13 | Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2419725A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0059817A1 (fr) * | 1981-03-11 | 1982-09-15 | Mirko Beljanski | Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales |
WO1994002829A1 (fr) * | 1992-07-28 | 1994-02-03 | Abraxas Bio Labs Sa | Methode de cytodiagnostic utilisant l'alstonine comme marqueur selectif et kit de diagnostic contenant ce marqueur |
WO2002094270A2 (fr) * | 2001-05-18 | 2002-11-28 | Chemokine Therapeutics Corporation | Medicaments a base de ligands de recepteurs mip-1 alpha destines aux maladies auto-immunes et a mediation par cellules t |
US11083714B2 (en) | 2018-03-31 | 2021-08-10 | Molecular International Research, Inc. | Selective anti-cancer agent effective for prevention and treatment |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1702M (fr) * | 1961-12-06 | 1963-02-18 | Smith Brothers | Composition pharmaceutique active contre la toux. |
-
1978
- 1978-03-13 FR FR7807155A patent/FR2419725A1/fr active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1702M (fr) * | 1961-12-06 | 1963-02-18 | Smith Brothers | Composition pharmaceutique active contre la toux. |
Non-Patent Citations (6)
Title |
---|
CA1947 * |
CA1959 * |
CA1968 * |
CA1969 * |
CA1970 * |
CA1974 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0059817A1 (fr) * | 1981-03-11 | 1982-09-15 | Mirko Beljanski | Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales |
WO1994002829A1 (fr) * | 1992-07-28 | 1994-02-03 | Abraxas Bio Labs Sa | Methode de cytodiagnostic utilisant l'alstonine comme marqueur selectif et kit de diagnostic contenant ce marqueur |
FR2694193A1 (fr) * | 1992-07-28 | 1994-02-04 | Abraxas Bio Labs Sa | Méthode de cytodiagnostic utilisant l'alstonine comme marqueur sélectif et kit de diagnostic contenant ce marqueur. |
US5567593A (en) * | 1992-07-28 | 1996-10-22 | Beljanski; Mirko | Cytodiagnostic method using alstonine as a selective marker, and diagnostic kit containing marker |
WO2002094270A2 (fr) * | 2001-05-18 | 2002-11-28 | Chemokine Therapeutics Corporation | Medicaments a base de ligands de recepteurs mip-1 alpha destines aux maladies auto-immunes et a mediation par cellules t |
WO2002094270A3 (fr) * | 2001-05-18 | 2003-04-03 | Chemokine Therapeutics Corp | Medicaments a base de ligands de recepteurs mip-1 alpha destines aux maladies auto-immunes et a mediation par cellules t |
US11083714B2 (en) | 2018-03-31 | 2021-08-10 | Molecular International Research, Inc. | Selective anti-cancer agent effective for prevention and treatment |
Also Published As
Publication number | Publication date |
---|---|
FR2419725B1 (fr) | 1981-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1558370A (en) | Blood treating apparatus | |
AU1775976A (en) | Irradiated laminates | |
GB1541278A (en) | Comounication system particularly suitable for establishing radioelectric communication in tunnels and along linear paths above the ground | |
JPS51136970A (en) | Small leather structure | |
YU39173B (en) | Machine for fullering tracks, particularly machine for fullering and levelling tracks | |
AU1488976A (en) | Polyether modified polyepoxide | |
ES471900A1 (es) | Procedimiento para preparar oxialquilenos polimeros | |
FR2419725A1 (fr) | Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales | |
AU504126B2 (en) | Abrasive throwing machine for treating horizontal or inclined surfaces | |
GB1553256A (en) | Coinoperated locker | |
AU1312276A (en) | Treatment for swine bysentery | |
GB1553255A (en) | Coinoperated locker | |
GB1541229A (en) | Radial ball bearing | |
CA1035704A (fr) | Machines a traiter les planchers | |
AU505739B2 (en) | Apparatus for pitting peaches | |
ES2187500T3 (es) | Uso de topotecano en el tratamiento del carcinoma pulmonar no de celulas pequeñas. | |
JPS51129451A (en) | Organic abrasive | |
GB1547167A (en) | Storage method and storage trolleys | |
ZA776546B (en) | Selectively herbicidally active diurethanes,process for their manufacture and their use | |
CA1013508A (en) | Method for treating leather | |
FR2322756A1 (fr) | Roulette pour meuble, notamment roulette orientable. | |
GB1557044A (en) | Nitrogen oxide catalysis | |
ATA575375A (de) | Teilweise in das erdreich versenkbare, transportable energieverteilungs- und bzw. oder energieerzeugungsstation | |
CS189163B1 (en) | Facility for cutting,concentration and lapping the wood | |
CA1019033A (en) | Apparatus and method for coronary prone patient urgent self treatment decision |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
TP | Transmission of property | ||
TP | Transmission of property | ||
SN | Distraint notified (in the national patent register) | ||
JU | Final juridical decision affecting the ownership or exploitation of an industrial property right | ||
ML | Cancellation of distraint | ||
TP | Transmission of property |